- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips unveils new CT and PET/CT platforms
Philips is adding to its portfolio a new line of CT scanners and a new line of PET/CTs based on dose-saving technologies. Ingenuity CT will displace Philips’ Brilliance line of CTs in configurations up to 128 slices; the Ingenuity TF PET/CT will displace the company’s Gemini platform of PET/CTs. Philips will not stop making these older models, but will feature them in its product portfolio as alternatives to the latest releases.
Philips is adding to its portfolio a new line of CT scanners and a new line of PET/CTs based on dose-saving technologies. Ingenuity CT will displace Philips’ Brilliance line of CTs in configurations up to 128 slices; the Ingenuity TF PET/CT will displace the company’s Gemini platform of PET/CTs. Philips will not stop making these older models, but will feature them in its product portfolio as alternatives to the latest releases.
The Ingenuity CT features iDose4, the company’s next-generation iterative reconstruction technique, which allows operators to choose vastly increased spatial resolution, substantially less dose, or some of both. Various points along the scale will allow a blend of the two. For example, scans at equivalent diagnostic quality but with up to 80% less dose, spatial resolution improved by as much as 35% with up to 50% less dose, or simply spatial resolution improved by up to 68%.
An added feature of the new CT platform is SyncRight, which leverages enhanced communications between the scanner and injector, creating consistent image quality from patient to patient and enabling up to a 15% reduction in injected contrast per patient. This promises better visualization of vascular structures, which will result in fewer repeat exams, according to the company.
The new IngenuityCT anchors the Ingenuity TF PET/CT system, which also improves on its Gemini predecessor’s time-of-flight (TOF) technology with Astonish TF, the next evolution of TOF. Astonish TF shows 50% improved contrast resolution, according to Philips, while maintaining quantitative accuracy with up to four times faster reconstruction compared with previous-generation systems.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.
